1. Home
  2. LPA vs BDSX Comparison

LPA vs BDSX Comparison

Compare LPA & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPA
  • BDSX
  • Stock Information
  • Founded
  • LPA 2013
  • BDSX 2005
  • Country
  • LPA United States
  • BDSX United States
  • Employees
  • LPA N/A
  • BDSX N/A
  • Industry
  • LPA
  • BDSX Precision Instruments
  • Sector
  • LPA
  • BDSX Health Care
  • Exchange
  • LPA Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • LPA 241.7M
  • BDSX 215.3M
  • IPO Year
  • LPA N/A
  • BDSX 2020
  • Fundamental
  • Price
  • LPA $10.02
  • BDSX $1.07
  • Analyst Decision
  • LPA
  • BDSX Strong Buy
  • Analyst Count
  • LPA 0
  • BDSX 4
  • Target Price
  • LPA N/A
  • BDSX $3.08
  • AVG Volume (30 Days)
  • LPA 24.9K
  • BDSX 318.9K
  • Earning Date
  • LPA 02-14-2025
  • BDSX 02-28-2025
  • Dividend Yield
  • LPA N/A
  • BDSX N/A
  • EPS Growth
  • LPA N/A
  • BDSX N/A
  • EPS
  • LPA N/A
  • BDSX N/A
  • Revenue
  • LPA $44,311,428.00
  • BDSX $65,562,000.00
  • Revenue This Year
  • LPA N/A
  • BDSX $46.97
  • Revenue Next Year
  • LPA N/A
  • BDSX $31.44
  • P/E Ratio
  • LPA N/A
  • BDSX N/A
  • Revenue Growth
  • LPA 22.46
  • BDSX 48.92
  • 52 Week Low
  • LPA $6.00
  • BDSX $1.07
  • 52 Week High
  • LPA $525.00
  • BDSX $2.21
  • Technical
  • Relative Strength Index (RSI)
  • LPA N/A
  • BDSX 30.25
  • Support Level
  • LPA N/A
  • BDSX $1.09
  • Resistance Level
  • LPA N/A
  • BDSX $1.51
  • Average True Range (ATR)
  • LPA 0.00
  • BDSX 0.10
  • MACD
  • LPA 0.00
  • BDSX -0.04
  • Stochastic Oscillator
  • LPA 0.00
  • BDSX 0.00

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns and manages a diversified portfolio of warehouse logistics assets in Central America and the South America. It focuses on modern Class A logistics real estate in high growth and high barrier-to-entry markets that are undersupplied and have low penetration rates.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: